Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis - Wikidata - wikimedia - TriplyDB

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis

http://www.wikidata.org/entity/Q28215493

about

sameAs

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer Gene expression profiling predicts clinical outcome of prostate cancer Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity Mammographic density is related to stroma and stromal proteoglycan expression BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer Transcriptomes of human prostate cells Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cells Cholesterol and benign prostate disease.Personalized medicine for the management of benign prostatic hyperplasia Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression.Extracellular influences on tumour angiogenesis in the aged host.Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition.A survey of commonalities relevant to function and dysfunction in pelvic and sexual organs.5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.Systems biology and cancer stem cells.A signaling network in phenylephrine-induced benign prostatic hyperplasia.Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine.Etiopathogenesis of benign prostatic hypeprlasia.Proteoglycans in prostate cancer.Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer.CONFAC: automated application of comparative genomic promoter analysis to DNA microarray datasets.Molecular classification of benign prostatic hyperplasia: A gene expression profiling study in a rat model.Widespread telomere instability in prostatic lesions.Proteoglycan expression in normal human prostate tissue and prostate cancer.Antrodan, a β-glucan obtained from Antrodia cinnamomea mycelia, is beneficial to benign prostate hyperplasia.Impact of oral capsule of Peganum harmala on alleviating urinary symptoms in men with benign prostatic hyperplasia; a randomized clinical trial BPH gene expression profile associated to prostate gland volume Developmental, cellular and molecular biology of benign prostatic hyperplasia.Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.The accumulation of versican in the nodules of benign prostatic hyperplasia.Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate.

P2860

Q24528253-1A33B707-709E-4D2C-8E63-89D5FA4D1751 Q24594253-5CB8B0BD-BEC5-47B8-878C-64EF30D76DFE Q24649675-22A51D1E-88EC-42CC-8125-6EBD2D7093A6 Q24803332-AC2E0D08-D955-4EE0-8CF8-C13330E0B5DD Q28585269-01E535FD-5B54-4818-86DB-28AA52C88208 Q31158946-ABA045F2-53FF-427E-ACCD-B3D97F7C79EF Q33241082-5CCC7F84-C8CC-4798-B5B8-36E686FB2E98 Q33397762-91540B77-0282-413A-B180-2947C5A3DEB9 Q33493120-0A6B53FA-8351-435E-976C-8216649047AA Q33520245-165D93BB-4989-4427-9DA8-7B7B8DB38819 Q33637491-96070C63-3347-4B0B-9D86-1020E8D1BF34 Q33732687-A52C04EB-4E09-4B53-898B-FCDB9952D2F7 Q34084593-7E4BA1EC-142B-4CE7-9E3A-C93D3D1164B4 Q34507732-56B6AE99-9CEE-42B4-956E-E432217DC522 Q34770064-338D9B70-B53B-4E4A-BFA8-C91DF713F2D0 Q36614769-04C6AA52-2F73-4C0B-8ECD-A0C338717B59 Q36628945-FC3CD296-1F36-4FE6-B0B8-142322237DD1 Q36918641-0FB4F08E-3F67-43ED-BDB5-36A66641A135 Q36932062-4B14A2F9-D64C-46B7-BE99-EEF9DF4957C4 Q36982102-0968F0AD-F5A7-40BC-9FC6-5D965C992AF6 Q37010408-7E6F96E2-DB0E-49CE-88DA-476AF62DB59C Q37281184-47550FE0-E0A9-4052-9EDB-6C4FAF798615 Q37365172-44526C83-3770-46D0-AE34-8B327CFEF057 Q37625720-86BEE610-5EBC-456D-A51D-5310AC7936F4 Q37986399-3A27ADBD-B153-402D-8F4E-189469AC7BAE Q38309500-6BC90656-E2E8-4A08-81D7-991FC5614952 Q38339706-F49A3550-5A52-4A65-8CE3-CAC443213BEE Q38447424-022C7168-1DED-4CD7-9A5C-D0F6D5579F91 Q38881676-BB5B2B37-5C82-4B1C-B55F-AD476EA48BBE Q40713205-F95165A1-8C52-4909-B7DB-F14F0DFD86F3 Q41653977-925754C8-F626-4EA3-9DDD-50A5A904C0FE Q41895631-127594D3-9ADD-4A22-88A2-2DEF442D4439 Q42103664-AAB52A80-454C-4848-B049-8A6A3CF7BE76 Q42269970-F5A65D03-F2B1-45EC-8BF2-50E211CBBFFD Q42373538-1FD4CF12-41CE-4EBC-8DA2-8EF035CBAA5C Q42476964-5F8C3AEF-F10D-416C-8CEC-7A38151D266F Q42702895-42603302-6ACB-48C2-A683-7D9BF1EB5670 Q47982349-0FAB19EB-E72D-49C8-B81E-7E61926AE8A5

P2860

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis

http://www.wikidata.org/entity/Q28215493

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Gene expression signature of b ...... ed by cDNA microarray analysis

@ast

Gene expression signature of b ...... ed by cDNA microarray analysis

@en

Gene expression signature of b ...... ed by cDNA microarray analysis

@nl

type

label

Gene expression signature of b ...... ed by cDNA microarray analysis

@ast

Gene expression signature of b ...... ed by cDNA microarray analysis

@en

Gene expression signature of b ...... ed by cDNA microarray analysis

@nl

prefLabel

Gene expression signature of b ...... ed by cDNA microarray analysis

@ast

Gene expression signature of b ...... ed by cDNA microarray analysis

@en

Gene expression signature of b ...... ed by cDNA microarray analysis

@nl

P1433

Q28215493-5CCAC5A5-1E39-434D-804F-18959FCFE497

P1476

Q28215493-CBB2B946-4627-4775-926F-A48E58379351

P2093

Q28215493-172533B9-F5B1-4DF6-936E-6E6705ABE117

Q28215493-346937FE-50D8-4B2A-9D5E-91A28A10CA99

Q28215493-57AC2237-3477-416A-B177-0820AF17B90F

Q28215493-611E3369-38DD-4869-BE4A-6ACAF05D5261

Q28215493-8B7E9CD0-9B28-46CA-BDB9-2B6C1DCB5AC9

Q28215493-B17A2794-E9C4-49FD-A7CB-551996FA5031

Q28215493-F3AD42E0-43F4-44FE-BE12-7259D053E65E

P2860

Q28215493-13001DD3-1A3E-4D5E-8C0B-B21E70756BCC

Q28215493-1655625D-D5B3-4E24-8669-11438DA1F293

Q28215493-2092DD5F-082E-438C-8452-618F372AB8A2

Q28215493-2A552D86-51AA-4AF9-AABD-5905EB2B3FBC

Q28215493-3B213D2E-659A-4A7F-B24F-790637C0D3BE

Q28215493-462167D1-4033-4415-BDE4-F45ABBDBD61B

Q28215493-584F2555-811C-4232-9EE6-DA5994629B45

Q28215493-59CB429C-B099-4423-978A-26D7DBC1A177

Q28215493-61F84E88-43CC-452A-A596-1A43AACE9ECE

Q28215493-7E199832-2558-49C0-8CE9-593BEE029910

P304

Q28215493-5A5DC96B-1DF8-44B9-AD6B-230724BD5E61

P31

Q28215493-EDC1AE85-123F-499A-9E4E-689F62E7DC65

P356

Q28215493-5888EBF5-EB6A-491C-9958-36949F505DCF

P407

Q28215493-BA92DB04-F41D-4067-AAC8-7E333C3C95AB

P433

Q28215493-52197EA4-AF96-4BAF-B0FF-B245F740881C

P478

Q28215493-11546797-F757-4112-B234-901D9BDD01D5

P577

Q28215493-9CE9C503-BA33-46C1-877C-EB7471CC0DB0

P698

Q28215493-3666EA75-04B9-4E27-8B3B-39A0EF69E55D

P356

P1433

P1476

Gene expression signature of b ...... ed by cDNA microarray analysis

@en

P2093

Charles Ewing

http://www.w3.org/2001/XMLSchema#string

Jeffrey Trent

http://www.w3.org/2001/XMLSchema#string

Jun Luo

http://www.w3.org/2001/XMLSchema#string

Jurga Sauvageot

http://www.w3.org/2001/XMLSchema#string

Thomas Dunn

http://www.w3.org/2001/XMLSchema#string

William Isaacs

http://www.w3.org/2001/XMLSchema#string

Yidong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of insulin receptor activation by insulin-like growth factor binding proteins

Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II

Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains

Molecular classification of cutaneous malignant melanoma by gene expression profiling

In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues.

Pieces of the puzzle: expressed sequence tags and the catalog of human genes.

New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.

P304

189-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.10087

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11967953

http://www.w3.org/2001/XMLSchema#string